Attached files
| file | filename |
|---|---|
| EX-99.1 - CORPORATE PRESENTATION - SOLIGENIX, INC. | f8k070113ex99i_soligenix.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): July 2, 2013
Commission File No. 000-16929
Soligenix, Inc.
(Exact name of small business issuer as specified in its charter)
|
DELAWARE
|
41-1505029
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification Number)
|
|
|
29 Emmons Drive,
Suite C-10
Princeton, NJ
|
08540
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
|
(609) 538-8200
|
||
|
(Issuer’s telephone number, including area code)
|
||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01
|
Regulation FD Disclosure.
|
Soligenix, Inc. (the “Company”) has updated its corporate presentation as of July 2, 2013. The slides from this presentation are attached hereto as Exhibit 99.1. The attached materials have also been posted on the Company’s website at www.soligenix.com. The Company does not undertake to update this presentation.
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits
|
Exhibit No.
|
Identification of Exhibits | |
|
99.1
|
Corporate Presentation |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Soligenix, Inc.
|
|||
|
July 2, 2013
|
By:
|
/s/ Christopher J. Schaber | |
| Christopher J. Schaber, PhD | |||
|
President and Chief Executive Officer
|
|||
|
(Principal Executive Officer)
|
|||
3